American University of Beirut Medical Center

🇱🇧Lebanon

Country: 🇱🇧Lebanon

Ownership: Private

Established: 1902-01-01

Employees: -

Market Cap: -

Website: http://www.aubmc.org/pages/home.aspx

Clinical Trials

Variable Rate Phenylephrine Infusion for Prevention of Spinal-induced Hypotension for Cesarean Delivery

Phase 4

Completed

Conditions: Anesthetic Complication Spinal

Interventions: Drug: Phenylephrine
Drug: saline

First Posted Date: 2011-06-22

Last Posted Date: 2014-08-26

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 80

Registration Number: NCT01378325

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Completed

Conditions: Escherichia Coli Infections
Klebsiella Pneumonia

First Posted Date: 2011-03-29

Last Posted Date: 2015-06-24

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 100

Registration Number: NCT01324726

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Vitamin C Efficacy in Reducing Post Operative Pain

Phase 4

Completed

Conditions: Gallbladder Inflammation

Interventions: Drug: Ascorbic Acid

First Posted Date: 2011-03-24

Last Posted Date: 2012-01-09

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 80

Registration Number: NCT01322061

Locations: 🇱🇧
AUBMC, Beirut, Lebanon

Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon

Completed

Conditions: Dehydration
Gastroenteritis

First Posted Date: 2011-03-23

Last Posted Date: 2023-11-18

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 1555

Registration Number: NCT01321216

Locations: 🇱🇧
Rafik Hariri University Hospital, Beirut, Lebanon
🇱🇧
American University of Beirut, Beirut, Lebanon
🇱🇧
Makassed General Hospital, Beirut, Lebanon

and more 1 locations

Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia

Not Applicable

Recruiting

Conditions: Chronic Myelogenous Leukemia

Interventions: Drug: Nilotinib

First Posted Date: 2011-03-16

Last Posted Date: 2024-01-31

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 25

Registration Number: NCT01316250

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Hypovitaminosis D : A Link Between Bone/Mineral and Fat/Fuel Metabolism

Phase 3

Completed

Conditions: Hypovitaminosis D
Insulin Resistance
Obesity
Osteoporosis

Interventions: Dietary Supplement: Euro D, Ci-CalD
Dietary Supplement: Euro D and Ci-CalD

First Posted Date: 2011-03-15

Last Posted Date: 2015-11-20

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 257

Registration Number: NCT01315366

Locations: 🇱🇧
American University of Beirut, Beirut, Lebanon

A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection

Phase 4

Completed

Conditions: Helicobacter Infections

Interventions: Drug: Rabeprazole, metronidazole, Clarithromycin, Amoxicillin

First Posted Date: 2010-10-13

Last Posted Date: 2014-01-27

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 200

Registration Number: NCT01219764

Locations: 🇱🇧
American University of Beirut - Medical Center, Beirut, Lebanon

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

Phase 2

Conditions: Respiratory Distress Syndrome, Newborn
Transient Tachypnea of the Newborn

Interventions: Drug: Betamethasone
Other: Normal Saline

First Posted Date: 2010-09-22

Last Posted Date: 2011-06-23

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 700

Registration Number: NCT01206946

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon
🇱🇧
Bahman Hospital, Beirut, Lebanon
🇱🇧
Rafik Hariri University Hospital, Beirut, Lebanon

and more 2 locations

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

Not Applicable

Completed

Conditions: Calcium Metabolism Disorders

Interventions: Drug: Rabeprazole or Esomeprazole or Lanzoprazole

First Posted Date: 2010-06-08

Last Posted Date: 2013-01-28

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 58

Registration Number: NCT01139645

Locations: 🇱🇧
American University of Beirut - Medical Center, Beirut, Lebanon

Aromatase Inhibitors for Treatment of Uterine Leiomyomas

Phase 1

Withdrawn

Conditions: Symptomatic or Large Uterine Fibroids

Interventions: Drug: Letrozole (aromatase inhibitor)

First Posted Date: 2009-07-24

Last Posted Date: 2012-07-13

Lead Sponsor: American University of Beirut Medical Center

Registration Number: NCT00945360

Locations: 🇱🇧
American University of Beirut, Beirut, Lebanon

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy